Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-22-001595
Filing Date
2022-02-24
Accepted
2022-02-24 16:39:31
Documents
2
Period of Report
2022-02-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 6376
2 youngpopa.txt EX-24 3671
  Complete submission text file 0001179110-22-001595.txt   11373
Mailing Address C/O ACADIA PHARMACEUTICALS INC. 3611 VALLEY CENTRE DRIVE, SUITE 300 SAN DIEGO CA 92130
Business Address
YOUNG TODD S. (Reporting) CIK: 0001682584 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38661 | Film No.: 22671774

Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Issuer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations